Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
EMD Serono
Seagen Inc.
Multitude Therapeutics Inc.
Seagen Inc.
Eli Lilly and Company
Pfizer
Merck Sharp & Dohme LLC
Sun Yat-sen University
Akeso
Summit Therapeutics
Fudan University
Eastern Cooperative Oncology Group
Pfizer
Seagen Inc.
AstraZeneca